Clorox (CLX) Stock Still Looks Fully Priced After ERP Supply Chain News
Clorox stock has recovered some ground in the short term, yet over the past five years shareholders have seen the share price decline about 23%, while current valuation checks still lean toward the shares looking expensive rather than like a clear bargain. Over the past five years, Clorox has delivered a share price decline of about 23%, which raises questions about how much long term value recent gains are really adding for holders. Management expects supply chain efficiencies from a new...
Yahoo13 days agoCLX

How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook
CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
Yahoo13 days agoCLX

Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure?
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
Yahoo13 days agoCLX

Clorox Stock Jumps 13.1% in a Month. Can the Gains Keep Building?
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
Yahoo13 days agoCLX

Colgate Raises 2026 Profit Outlook After Q2 Earnings Beat and Margin Gains
CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.
Yahoo13 days agoCLX
Is Colgate Stock a Buy as Growth Improves but Valuation Stays Rich?
CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.
Yahoo13 days agoCLX
Clorox: Shares Aren't Cheap Enough To Offer Clean Upside
The Clorox Company remains a market leader but faces recent revenue and profit declines. Click here to read this latest analysis of CLX stock.
SeekingAlpha14 days agoCLX

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?
As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Yahoo22 days agoCLX

Is ENR a Buy as Low Valuation Clashes With Weak Growth and Margins?
ENR trades at a steep discount, but weak earnings, margin pressure and soft battery demand challenge the case for a rebound.
Yahoo22 days agoCLX
The Top 5 Analyst Questions From Clorox’s Q2 Earnings Call
Clorox’s second quarter generated a positive response from investors, as revenue surpassed analyst expectations despite a 2% year-over-year decline. Management attributed the quarter’s performance to targeted improvements in product superiority, focused brand investments, and effective promotional execution in key categories. CEO Linda Rendle noted that, “the majority of our businesses are performing at or above expectations,” while acknowledging operational challenges in segments like Litter an
Yahoo23 days agoCLX

Clorox (CLX) Q4 2026 Earnings Call Transcript
GOJO acquisition boosts health segment as organic sales decline amid inflation headwinds.
Yahoo24 days agoCLX

Clorox says ERP transition will provide supply chain gains this year
The household cleaning and consumer products maker expects improvements through better planning, lower inventory levels and more automation.
Yahoo24 days agoCLX

Clorox expects $200M inflation hit, supply chain costs a factor
Increasing energy, commodity and supplier costs are significant contributors, along with higher trucking, ocean freight and logistics-related expenses.
Yahoo25 days agoCLX
